William L Carroll Selected Research

Pancreatitis

1/2018	Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131.
1/2016	Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.
7/2013	Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William L Carroll Research Topics

Disease

103	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2023 - 01/2003
25	Neoplasms (Cancer) 10/2023 - 01/2003
23	Leukemia 12/2022 - 10/2002
15	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023 - 08/2006
13	Residual Neoplasm 05/2023 - 01/2009
7	Philadelphia Chromosome 01/2018 - 06/2009
5	Hypersensitivity (Allergy) 12/2023 - 07/2013
5	Infections 01/2021 - 08/2008
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 01/2007
3	Osteonecrosis (Kienbock's Disease) 12/2023 - 10/2015
3	Lymphoma (Lymphomas) 11/2023 - 08/2014
3	Hemorrhage 08/2023 - 07/2013
3	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 01/2012
3	Pancreatitis 01/2018 - 07/2013
2	Thrombosis (Thrombus) 08/2023 - 07/2013
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 02/2015
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2016 - 01/2007
2	Glucocorticoid Receptor Deficiency 06/2015 - 07/2014
1	Hypoprothrombinemias (Prothrombin Deficiency) 08/2023
1	Genetic Risk Score 12/2022
1	Hyperbilirubinemia 12/2022
1	Severe Acute Respiratory Syndrome 01/2021
1	Central Nervous System Diseases (CNS Diseases) 10/2020
1	Necrosis 03/2020
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 03/2020
1	B-Cell Leukemia (Leukemia, B Cell) 01/2020
1	Bites and Stings (Sting) 10/2019

Drug/Important Bio-Agent (IBA)

10	Asparaginase (Elspar)FDA Link 12/2023 - 07/2013
9	Methotrexate (Mexate)FDA LinkGeneric 12/2022 - 07/2011
9	pegaspargase (Oncaspar)FDA Link 10/2021 - 07/2013
8	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 05/2006
6	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 12/2022 - 06/2012
6	Proteins (Proteins, Gene)FDA Link 06/2021 - 09/2002
6	Phosphotransferases (Kinase)IBA 01/2017 - 04/2009
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 10/2016
4	nelarabine (506U78)FDA Link 10/2020 - 08/2012
4	GlucocorticoidsIBA 01/2018 - 06/2015
3	MethyltransferasesIBA 10/2023 - 04/2009
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2023 - 12/2011
3	ChromatinIBA 01/2023 - 07/2014
3	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 02/2015
3	Prednisone (Sone)FDA LinkGeneric 01/2020 - 08/2012
3	Monoclonal AntibodiesIBA 01/2018 - 08/2008
3	Cytokine Receptors (Cytokine Receptor)IBA 01/2017 - 07/2010
3	RNA (Ribonucleic Acid)IBA 07/2015 - 03/2013
2	Cyclin DIBA 11/2023 - 01/2022
2	palbociclibIBA 11/2023 - 01/2022
2	lestaurtinibIBA 05/2021 - 01/2021
2	AntigensIBA 01/2021 - 10/2019
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 08/2014
2	Leucovorin (Folinic Acid)FDA Link 10/2020 - 10/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2019 - 08/2017
2	2-mercaptopurineIBA 10/2019 - 01/2018
2	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 12/2011
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019 - 01/2012
2	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 11/2009
2	Clofarabine (Clolar)FDA Link 01/2018 - 12/2011
2	Transcription Factors (Transcription Factor)IBA 08/2017 - 09/2014
2	Thioguanine (Tioguanine)FDA Link 05/2017 - 06/2015
2	NucleotidesIBA 05/2017 - 06/2015
2	epratuzumabIBA 07/2015 - 08/2008
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 06/2015 - 07/2014
2	Anaplastic Lymphoma KinaseIBA 01/2015 - 09/2002
2	Messenger RNA (mRNA)IBA 08/2014 - 04/2012
2	Tyrosine (L-Tyrosine)FDA Link 01/2013 - 06/2009
2	Histone Deacetylase InhibitorsIBA 05/2012 - 04/2009
2	Janus KinasesIBA 09/2011 - 07/2010
2	ProteomeIBA 01/2007 - 05/2006
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 08/2023
1	CoagulantsIBA 08/2023
1	Rituximab (Mabthera)FDA Link 08/2023
1	SteroidsIBA 08/2023
1	Lysine (L-Lysine)FDA Link 05/2023
1	Alanine Transaminase (SGPT)IBA 12/2022
1	Transaminases (Aminotransferases)IBA 12/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2022
1	Mitogen-Activated Protein KinasesIBA 10/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2022
1	Cytotoxins (Cytolysins)IBA 01/2022
1	ribociclibIBA 01/2022
1	Drug CombinationsIBA 01/2022
1	Cyclin D3IBA 01/2022
1	Antigen Receptors (Antigen Receptor)IBA 04/2021
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	IntegrinsIBA 01/2020
1	AntimetabolitesIBA 01/2020
1	ElementsIBA 12/2019
1	Chimeric Antigen ReceptorsIBA 10/2019
1	Immune Checkpoint InhibitorsIBA 10/2019

Therapy/Procedure

58	Therapeutics 12/2023 - 01/2003
33	Drug Therapy (Chemotherapy) 11/2023 - 06/2006
3	Hematopoietic Stem Cell Transplantation 01/2019 - 04/2009
3	Cranial Irradiation 10/2018 - 02/2016
3	Remission Induction 01/2017 - 01/2009
3	Precision Medicine 02/2016 - 08/2014
2	Induction Chemotherapy 11/2023 - 01/2018
2	Immunotherapy 10/2020 - 01/2018
1	Radiotherapy 12/2021
1	Neoadjuvant Therapy 03/2020